|
1
|
Malik SS, Tahir M, Ahmed U, Evans S, Jeys
L and Abudu S: Outcome of Ewing's sarcoma of the scapula-a
long-term follow-up study. Orthop Traumatol Surg Res. 106:25–30.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bernstein M, Kovar H, Paulussen M, Randall
RL, Schuck A, Teot LA and Juergens H: Ewing's sarcoma family of
tumors: Current management. Oncologist. 11:503–519. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yeung CM, Kaiser CL, Peleteiro-Pensado M,
Barrientos-Ruiz I, Ortiz-Cruz EJ, Anderson ME, Raskin KA and
Lozano-Calderón SA: Characteristics and oncologic outcomes of
patients with Ewing sarcoma of the scapula. Surg Oncol.
38:1016192021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pretz JL, Barysauskas CM, George S,
Hornick JL, Raut CP, Chen YLE, Marcus KJ, Choy E, Hornicek F, Ready
JE, et al: Localized adult ewing sarcoma: Favorable outcomes with
alternating vincristine, doxorubicin, cyclophosphamide, and
ifosfamide, etoposide (VDC/IE)-based multimodality therapy.
Oncologist. 22:1265–1270. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Grier HE, Krailo MD, Tarbell NJ, Link MP,
Fryer CJH, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ,
Meyers PA, et al: Addition of ifosfamide and etoposide to standard
chemotherapy for Ewing's sarcoma and primitive neuroectodermal
tumor of bone. N Engl J Med. 348:694–701. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Womer RB, West DC, Krailo MD, Dickman PS,
Pawel BR, Grier HE, Marcus K, Sailer S, Healey JH, Dormans JP and
Weiss AR: Randomized controlled trial of interval-compressed
chemotherapy for the treatment of localized Ewing sarcoma: A report
from the Children's Oncology Group. J Clin Oncol. 30:4148–4154.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ipponi E, Cordoni M, Bechini E, Gentili F,
Cosseddu F, Campo FR, D'Arienzo A and Andreani L: Clinical and
functional results after total scapulectomy in orthopedic oncology:
Are custom-made scapular prostheses better than humeral suspension?
Proc (Bayl Univ Med Cent). 37:553–559. 2024.PubMed/NCBI
|
|
8
|
Ahmed SK, Randall RL, DuBois SG, Harmsen
WS, Krailo M, Marcus KJ, Janeway KA, Geller DS, Sorger JI, Womer
RB, et al: Identification of patients with localized ewing sarcoma
at higher risk for local failure: A report from the children's
oncology group. Int J Radiat Oncol Biol Phys. 99:1286–1294. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Choi Y, Lim DH, Lee SH, Lyu CJ, Im JH, Lee
YH and Suh CO: Role of radiotherapy in the multimodal treatment of
ewing sarcoma family tumors. Cancer Res Treat. 47:904–912. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Imai R, Kamada T and Araki N; Working
Group for Carbon Ion Radiotherapy for Bone, : Soft Tissue Sarcomas:
Carbon ion radiotherapy for unresectable localized axial soft
tissue sarcoma. Cancer Med. 7:4308–4314. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Matsunobu A, Imai R, Kamada T, Imaizumi T,
Tsuji H, Tsujii H, Shioyama Y, Honda H and Tatezaki SI; Working
Group for Bone, : Soft Tissue Sarcomas: Impact of carbon ion
radiotherapy for unresectable osteosarcoma of the trunk. Cancer.
118:4555–4563. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kanai T, Endo M, Minohara S, Miyahara N,
Koyama-ito H, Tomura H, Matsufuji N, Futami Y, Fukumura A, Hiraoka
T, et al: Biophysical characteristics of HIMAC clinical irradiation
system for heavy-ion radiation therapy. Int J Radiat Oncol Biol
Phys. 44:201–210. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ohno T, Kanai T, Yamada S, Yusa K, Tashiro
M, Shimada H, Torikai K, Yoshida Y, Kitada Y, Katoh H, et al:
Carbon ion radiotherapy at the gunma university heavy ion medical
center: New facility set-up. Cancers (Basel). 3:4046–4060. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Iwata S, Yonemoto T, Ishii T, Kumagai K,
Imai R, Hagiwara Y, Kamada T and Tatezaki SI: Efficacy of
carbon-ion radiotherapy and high-dose chemotherapy for patients
with unresectable Ewing's sarcoma family of tumors. Int J Clin
Oncol. 18:1114–1118. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pritsch T, Bickels J, Wu CC, Squires MH
and Malawer MM: Is scapular endoprosthesis functionally superior to
humeral suspension? Clin Orthop Relat Res. 456:188–195. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Salunke AA, Nandy K, Kamani M, Parmar R,
Bharwani N, Pathak S, Patel K and Pandya S: Is polypropylene mesh
reconstruction functionally superior to non reconstructive group
following total scapular resection? A retrospective analysis of 16
patients and a systematic review of the literature. J Orthop.
52:37–48. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Burris HA and Hurtig J: Radiation recall
with anticancer agents. Oncologist. 15:1227–1237. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Camidge R and Price A: Characterizing the
phenomenon of radiation recall dermatitis. Radiother Oncol.
59:237–245. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Stiller CA, Trama A, Serraino D, Rossi S,
Navarro C, Chirlaque MD and Casali PG; RARECARE Working Group, :
Descriptive epidemiology of sarcomas in Europe: Report from the
RARECARE project. Eur J Cancer. 49:684–695. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fukushima T, Ogura K, Akiyama T, Takeshita
K and Kawai A: Descriptive epidemiology and outcomes of bone
sarcomas in adolescent and young adult patients in Japan. BMC
Musculoskelet Disord. 19:2972018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wytiaz V, Schwartz E, Rice JD, Zhao L,
Jasty R, Schuetze S and Chugh R: Disparate outcomes, biologic and
therapeutic differences in pediatric versus adult patients with
ewing sarcoma. Oncology. 102:1–8. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gupta AA, Pappo A, Saunders N, Hopyan S,
Ferguson P, Wunder J, O'Sullivan B, Catton C, Greenberg M and
Blackstein M: Clinical outcome of children and adults with
localized Ewing sarcoma: Impact of chemotherapy dose and timing of
local therapy. Cancer. 116:3189–3194. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takenaka S, Araki N, Outani H, Hamada KI,
Yoshikawa H, Kamada T and Imai R: Complication rate, functional
outcomes, and risk factors associated with carbon ion radiotherapy
for patients with unresectable pelvic bone sarcoma. Cancer.
126:4188–4196. 2020. View Article : Google Scholar : PubMed/NCBI
|
